Oral vitamin D modulates the epidermal expression of the vitamin D receptor and cathelicidin in children with atopic dermatitis.
Quick Facts
What This Study Found
Serum vitamin D levels increased from 45.1 to 93.5 nmoL/L, and AD severity decreased from 41.4 to 31.5 SCORAD.
Key Numbers
How They Did This
An open-label study with 22 children receiving weekly oral vitamin D3 for six weeks, measuring skin and serum markers.
Why This Research Matters
This research highlights the potential of vitamin D as a simple intervention to improve skin health in children with eczema, which could lead to better management strategies.
What This Study Doesn't Tell Us
The study had a small sample size and lacked a control group, which may affect the reliability of the findings.
Trust & Context
- Original Title:
- Oral vitamin D modulates the epidermal expression of the vitamin D receptor and cathelicidin in children with atopic dermatitis.
- Published In:
- Archives of dermatological research, 315(4), 761-770 (2023)
- Authors:
- Cabalín, Carolina, Pérez-Mateluna, Guillermo, Iturriaga, Carolina, Camargo, Carlos A, Borzutzky, Arturo
- Database ID:
- RPEP-06767
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06767APA
Cabalín, Carolina; Pérez-Mateluna, Guillermo; Iturriaga, Carolina; Camargo, Carlos A; Borzutzky, Arturo. (2023). Oral vitamin D modulates the epidermal expression of the vitamin D receptor and cathelicidin in children with atopic dermatitis.. Archives of dermatological research, 315(4), 761-770. https://doi.org/10.1007/s00403-022-02416-1
MLA
Cabalín, Carolina, et al. "Oral vitamin D modulates the epidermal expression of the vitamin D receptor and cathelicidin in children with atopic dermatitis.." Archives of dermatological research, 2023. https://doi.org/10.1007/s00403-022-02416-1
RethinkPeptides
RethinkPeptides Research Database. "Oral vitamin D modulates the epidermal expression of the vit..." RPEP-06767. Retrieved from https://rethinkpeptides.com/research/cabalin-2023-oral-vitamin-d-modulates
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.